Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery
Peri-operative Tamsulosin and Impact on Voiding Trial Following Outpatient Urogynecology Surgery: a Randomized Controlled Trial
TriHealth Inc.
166 participants
Feb 3, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of this research study is to determine if taking tamsulosin preoperatively decreases your chances of being discharged after surgery with a Foley catheter (flexible tube that drains urine from the bladder into a collection bag).
Eligibility
Inclusion Criteria1
- \- Patients undergoing any pelvic organ prolapse repair or incontinence surgery
Exclusion Criteria11
- Any surgery involving a non-urogynecologist
- Patients already on an alpha blocker
- Baseline hypotension
- History of syncope
- Postural orthostatic tachycardia syndrome (POTS)
- Non-English speaker or interpreter unavailable for Spanish-speaking patient
- Impaired cognition impeding proper consenting
- Any other medical contraindication for tamsulosin use
- History of urinary retention requiring continuous or intermittent catheterization
- Patients consented for the study but then due to intraoperative complication, routine voiding trial no longer indicated due to requiring indwelling catheter or intermittent catheterization on discharge will be excluded from primary outcome analysis
- Pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This intervention will investigate if tamsulosin will decrease postoperative urinary retention. Subjects will be directed to start taking the medication 5-7 days prior to their procedure; as previous studies have shown, this is when tamsulosin reaches its steady state. Patients will continue to take their assigned pills for 7 days postoperatively.
This intervention will ensure blinding and an accurate measure of the real effect of tamsulosin.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06843538